Senior Vice President, Global Supply Chain
Paul Granadillo has served as Moderna’s Head of Supply Chain since April 2018. Paul has 19-years’ experience in Supply Chain, Manufacturing, and Operational Excellence at Pharmaceutical companies including Eli Lilly and Company and Novartis. Paul has focused the past 11 years on transforming and building Supply Chain systems, processes, and organizations in pharmaceuticals from clinical supply through commercial at manufacturing sites and global levels. Through ascending Supply Chain responsibility in the US, Turkey, and Switzerland, Paul has global experience implementing MRPII Class A Supply Chains, Lean Methodology, and Organizational Change Management.
At Moderna, Paul has built Supply Chain from a from clinical supply through commercial supply. Starting in 2020, Paul transformed Moderna’s supply chain through the COVID-19 development, material sourcing, scale-up, commercialization, and mass production. Moderna rapidly established internal production, contract manufacturing, and third-party logistics capabilities to meet pandemic requirements. To date, Moderna has distributed more than 1,000,000,000 of COVID-19 vaccine doses globally.
Paul has a B.S. in Industrial Technology from Purdue University, is a Certified Lean Six Sigma Black Belt, and is currently enrolled in the General Management Program at Harvard Business School.
Director, Business Development
Founder & CEO